NCT00198276View on ClinicalTrials.gov

Study Using the MedPulser Electroporation System With Bleomycin to Treat Cutaneous and Subcutaneous Cancer

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions

Cancer

Interventions

COMBINATION_PRODUCT

MedPulser Electroporation with bleomycin

The MedPulser device will be used in combination with Bleomycin Sulfate injection around the tumor area in a concentration of 1 U/ml per cm3 of tumor treatment area.

Trial Locations (1)

92121

Inovio Biomedical Corporation, San Diego